Holen Sie sich die Stockscreener-App
1.04
48.00%
-0.96
Finanzdaten der Galectin Therapeutics Inc-Aktie (GALT)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
0.91%
9.648
|
9.561 | 9.166 | 9.003 | 10.34 |
| Interest Income/Expense |
24.20%
1.052
|
0.847 | 0.835 | 0.65 | 0.46 |
| Operating Income/Loss |
0.91%
-9.648
|
-9.561 | -9.166 | -9.003 | -10.34 |
| Nonoperating Income/Loss |
322.25%
-1.841
|
-0.436 | -1.262 | -0.111 | -1.185 |
| Income/Loss From Continuing Operations Before Tax |
14.92%
-11.49
|
-9.997 | -10.43 | -9.114 | -11.53 |
| Income/Loss From Continuing Operations After Tax |
14.92%
-11.49
|
-9.997 | -10.43 | -9.114 | -11.53 |
|
Net Income/Loss
|
14.92%
-11.49
|
-9.997 | -10.43 | -9.114 | -11.53 |
| Preferred Stock Dividends And Other Adjustments |
87.30%
0.008
|
0.063 | -0.006 | 0.063 | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
10,792%
61.98
|
0.569 | 59.70 | 59.58 | 59.48 |
| Diluted Average Shares |
10,792%
61.98
|
0.569 | 59.70 | 59.58 | 59.48 |
| Basic Earnings Per Share |
18.75%
-0.19
|
-0.16 | -0.24 | -0.15 | -0.19 |
| Diluted Earnings Per Share |
18.75%
-0.19
|
-0.16 | -0.24 | -0.15 | -0.19 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
87.30%
0.008
|
0.063 | -0.006 | 0.063 | - |
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):